KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
13.38
-0.12 (-0.89%)
At close: Sep 17, 2025, 4:00 PM EDT
13.57
+0.19 (1.42%)
After-hours: Sep 17, 2025, 7:50 PM EDT

KalVista Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is May - Apr.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Jul '25 Apr '25 Apr '24 Apr '23 Apr '22 Apr '21 2016 - 2020
Net Income
-203.1-183.44-126.64-92.91-82.34-46.24
Upgrade
Depreciation & Amortization
0.970.940.820.720.560.54
Upgrade
Loss (Gain) From Sale of Investments
-1.83-1.55-1.231.133.150.53
Upgrade
Stock-Based Compensation
14.6312.2921.929.9211.097.12
Upgrade
Other Operating Activities
9.493.820.75-1.531.73-0.46
Upgrade
Change in Accounts Receivable
-1.93-----
Upgrade
Change in Accounts Payable
-3.96-4.974.321.111.690.15
Upgrade
Change in Unearned Revenue
11.0510.56----
Upgrade
Change in Other Net Operating Assets
7.489.4510.856.31-14.018.2
Upgrade
Operating Cash Flow
-167.19-152.91-89.23-75.26-78.13-30.17
Upgrade
Capital Expenditures
-0.7-0.43-0.04-1.2-0.93-0.08
Upgrade
Sale (Purchase) of Intangibles
-0.58-0.5-0.4---
Upgrade
Investment in Securities
76.491.95-84.2842.6158.79-147.57
Upgrade
Investing Cash Flow
75.1291.02-84.7241.4257.86-147.65
Upgrade
Issuance of Common Stock
59.9861.6997.5957.031.58212.12
Upgrade
Other Financing Activities
119.9698.0453.121.09--
Upgrade
Financing Cash Flow
179.94159.73150.7158.121.58212.12
Upgrade
Foreign Exchange Rate Adjustments
5.252.64-1.211.24-1.170.51
Upgrade
Net Cash Flow
93.12100.48-24.4525.51-19.8634.8
Upgrade
Free Cash Flow
-167.89-153.34-89.27-76.46-79.07-30.25
Upgrade
Free Cash Flow Margin
-11773.63%-----
Upgrade
Free Cash Flow Per Share
-3.26-3.09-2.43-2.74-3.23-1.58
Upgrade
Levered Free Cash Flow
-100.21-92.91-50.27-52.01-60.09-21.2
Upgrade
Unlevered Free Cash Flow
-94.39-89.29-50.27-52.01-60.09-21.2
Upgrade
Change in Working Capital
12.6515.0415.177.41-12.328.35
Upgrade
Updated Sep 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q